Testing two eye treatments for dry eye symptoms
Part of Eyes & vision clinical trials.
This trial compares two different dry-eye eye drops to see which works better and is safe. You may be able to join if you’ve had dry eye for at least 3 months and meet specific eye-test results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have dry eye in both eyes for at least 3 months and still need artificial tears
- Have at least one eye with an Oxford score between 4 and 9
- Have at least one objective sign that your tears are too low or not working well
- Have health insurance and be able to follow study instructions
- Avoid certain recent or ongoing eye factors, like new contact lens use or recent changes with drops
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether BUFY01 eye drops work better than SVS20 for treating dry eye disease. You may be able to join if you have dry eye symptoms for at least 3 months and meet eye exam score and tear-test requirements.
This trial tests a new eye drop called PRO-240 versus Optive artificial tears in healthy adults. You will attend several visits over a few weeks and use the assigned drops as directed. The goal is to see if the new drop is as safe and comfortable as the standard one.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
This study tests different doses of an investigational eye drop (BRM421) to see if it safely helps people with dry eye disease. It may be an option if you have had dry eyes for a while and are looking for a new treatment.
This study tests a new lubricating eye drop designed to relieve dry eye symptoms. If you have dry eye disease, this trial may help determine if the new formula works better than what's currently available.
This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.
Hear when a new Dry Eye Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.